JP2023514576A5 - - Google Patents

Info

Publication number
JP2023514576A5
JP2023514576A5 JP2022548912A JP2022548912A JP2023514576A5 JP 2023514576 A5 JP2023514576 A5 JP 2023514576A5 JP 2022548912 A JP2022548912 A JP 2022548912A JP 2022548912 A JP2022548912 A JP 2022548912A JP 2023514576 A5 JP2023514576 A5 JP 2023514576A5
Authority
JP
Japan
Prior art keywords
sequence
oligonucleotide
mir
lna
compound according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022548912A
Other languages
English (en)
Japanese (ja)
Other versions
JP7863883B2 (ja
JP2023514576A (ja
Filing date
Publication date
Priority claimed from US16/792,103 external-priority patent/US11339392B2/en
Application filed filed Critical
Priority claimed from PCT/US2021/018025 external-priority patent/WO2021201996A1/en
Publication of JP2023514576A publication Critical patent/JP2023514576A/ja
Publication of JP2023514576A5 publication Critical patent/JP2023514576A5/ja
Priority to JP2026000520A priority Critical patent/JP2026042885A/ja
Application granted granted Critical
Publication of JP7863883B2 publication Critical patent/JP7863883B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022548912A 2020-02-14 2021-02-12 呼吸器ウイルスに対する汎遺伝子型薬剤及びそれを使用する方法 Active JP7863883B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2026000520A JP2026042885A (ja) 2020-02-14 2026-01-05 呼吸器ウイルスに対する汎遺伝子型薬剤及びそれを使用する方法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US16/792,103 2020-02-14
US16/792,103 US11339392B2 (en) 2016-03-02 2020-02-14 Pan-genotypic agents against influenza virus and methods of using the same
US202062992659P 2020-03-20 2020-03-20
US62/992,659 2020-03-20
PCT/US2021/018025 WO2021201996A1 (en) 2020-02-14 2021-02-12 Pan-genotypic agents against respiratory viruses and methods of using the same

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026000520A Division JP2026042885A (ja) 2020-02-14 2026-01-05 呼吸器ウイルスに対する汎遺伝子型薬剤及びそれを使用する方法

Publications (3)

Publication Number Publication Date
JP2023514576A JP2023514576A (ja) 2023-04-06
JP2023514576A5 true JP2023514576A5 (enExample) 2024-05-16
JP7863883B2 JP7863883B2 (ja) 2026-05-22

Family

ID=77929340

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022548912A Active JP7863883B2 (ja) 2020-02-14 2021-02-12 呼吸器ウイルスに対する汎遺伝子型薬剤及びそれを使用する方法

Country Status (2)

Country Link
JP (1) JP7863883B2 (enExample)
WO (1) WO2021201996A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021177773A2 (ko) * 2020-03-06 2021-09-10 (주)지노믹트리 Sars-cov-2 진단용 조성물, 키트 및 이를 이용한 sars-cov-2의 진단방법
CN115976271B (zh) * 2021-10-14 2025-04-25 深圳华大智造科技股份有限公司 流感与新型冠状病毒全基因组共扩增引物池及其建库方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040242518A1 (en) * 2002-09-28 2004-12-02 Massachusetts Institute Of Technology Influenza therapeutic
WO2005013901A2 (en) * 2003-07-31 2005-02-17 Isis Pharmaceuticals, Inc. Oligomeric compounds and compositions for use in modulation of small non-coding rnas
US20050182005A1 (en) * 2004-02-13 2005-08-18 Tuschl Thomas H. Anti-microRNA oligonucleotide molecules
US8357664B2 (en) * 2004-10-26 2013-01-22 Avi Biopharma, Inc. Antisense antiviral compound and method for treating influenza viral infection
CA2603842A1 (en) * 2005-04-08 2006-10-19 Nastech Pharmaceutical Company Inc. Rnai therapeutic for respiratory virus infection
CA3042781C (en) * 2006-04-03 2021-10-19 Roche Innovation Center Copenhagen A/S Pharmaceutical composition comprising anti-mirna antisense oligonucleotides
US20090042823A1 (en) * 2007-08-10 2009-02-12 Mdrna, Inc. Uses of broad spectrum rnai therapeutics against influenza
WO2013166264A2 (en) * 2012-05-02 2013-11-07 University Of Georgia Research Foundation, Inc. Methods for altering virus replication
US10597658B2 (en) * 2016-03-02 2020-03-24 The Board Of Trustees Of The Leland Stanford Junior University Pan-genotypic agents against influenza virus and methods of using the same

Similar Documents

Publication Publication Date Title
US5194428A (en) Inhibition of influenza virus replication by oligonucleotide phosphorothioates
US5567604A (en) Anti-viral guanosine-rich oligonucleotides
US7495088B1 (en) Modified nucleotide compounds
HUT76094A (en) Oligonucleotide n3'-p5' phosphoramidates: synthesis and compounds; hybridization and nuclease resistance properties
JP2020512845A5 (enExample)
CA2457528A1 (en) Rna interference mediated inhibition of hepatitis c virus (hcv) gene expression using short interfering nucleic acid (sina)
AU2129897A (en) Rnase l activators and antisense oligonucleotides effective to treat rsv infections
RU2014130600A (ru) Антисмысловые нуклеиновые кислоты
FI3717646T3 (fi) Angelmanin oireyhtymän antisense-hoito
JP2023138687A (ja) Ｂ型肝炎感染の治療用のＰＡＰＤ５及びＰＡＰＤ７ ｍＲＮＡを低減させるための核酸分子
KR930701466A (ko) 안티센스 올리고뉴클레오티드에 의한 a형 인플루엔자 바이러스, 안 아아보 스트레인(ann arbor strain)h2n2의 억제
KR960701077A (ko) 올리고누클레오티드 알킬포스포네이트 및 알킬포스포노티오에이트(oligonucleotide alkylphosphonates and alkylphosphonothioates)
JP2016521556A5 (enExample)
AU6527094A (en) Modified oligonucleotides having improved anti-influenza activity
WO1994007367A9 (en) Anti-viral oligomers that bind polypurine tracts of single-stranded rna or rna-dna hybrids
JP2019533472A5 (enExample)
Berhanu et al. Molecular characterization of partial fusion gene and C-terminus extension length of haemagglutinin-neuraminidase gene of recently isolated Newcastle disease virus isolates in Malaysia
US5637573A (en) Influenza virus replication inhibiting oligonucleotide analogues and their pharmaceutical compositions
US6087484A (en) Enhancement of ribozyme catalytic activity by A 2'-O-substituted facilitator oligonucleotide
JP2008500817A5 (ja) Ｄｎａウイルスのマイクロｒｎａ及びそれを阻害する医薬品
CN115702006A (zh) 缀合基团及其缀合物
CA2204870A1 (en) Ribozyme analogs
FI3800257T3 (fi) Pan-genotyyppisiä aineita influenssavirusta vastaan ja menetelmiä niiden käyttämiseksi
JP2023506842A5 (enExample)
WO2003062258A1 (en) Rnase l activator-antisense complexes